|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Turning Point Therapeutics, Inc. (TPTX) |
|
|
$76.01 0.00 (0.00%) as of 4:30 Tue 8/16
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
48,170,000 |
| Market
Cap: |
3.66(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$76.01 - $76.01 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 116 |
| Guru Rank Value : 7.9 |
| Guru Occurances : 1 |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
1,183 |
| Total Sell Value |
$0 |
$0 |
$0 |
$88,654 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  North Annette |
EVP, General Counsel & Secty. |
• – – |
2021-02-02 |
4 |
OE |
$17.00 |
$153,272 |
D/D |
9,016 |
9,016 |
|
- |
|
| Larson Yi |
EVP & Chief Financial Officer |
• – – |
2021-02-01 |
4 |
AS |
$122.94 |
$1,941,105 |
D/D |
(15,702) |
2,704 |
|
-40% |
|
| Larson Yi |
EVP & Chief Financial Officer |
• – – |
2021-02-01 |
4 |
OE |
$54.03 |
$848,379 |
D/D |
15,702 |
18,406 |
|
- |
|
| North Annette |
EVP, General Counsel & Secty. |
• – – |
2021-02-01 |
4 |
AS |
$122.58 |
$1,976,374 |
D/D |
(15,984) |
0 |
|
-40% |
|
| North Annette |
EVP, General Counsel & Secty. |
• – – |
2021-02-01 |
4 |
OE |
$17.00 |
$271,728 |
D/D |
15,984 |
15,984 |
|
- |
|
| Baker Brian Lee |
SVP of Finance and Admin. |
• – – |
2021-01-07 |
4 |
AS |
$120.16 |
$3,819,090 |
D/D |
(31,238) |
1,008 |
|
-44% |
|
| Baker Brian Lee |
SVP of Finance and Admin. |
• – – |
2021-01-07 |
4 |
OE |
$2.19 |
$132,918 |
D/D |
28,438 |
32,246 |
|
- |
|
| Hirmand Mohammad |
EVP and Chief Medical Officer |
• – – |
2021-01-05 |
4 |
AS |
$120.00 |
$150,360 |
D/D |
(1,253) |
284 |
|
-43% |
|
| Hirmand Mohammad |
EVP and Chief Medical Officer |
• – – |
2021-01-05 |
4 |
OE |
$54.73 |
$68,577 |
D/D |
1,253 |
1,537 |
|
- |
|
| Hirmand Mohammad |
EVP and Chief Medical Officer |
• – – |
2021-01-04 |
4 |
AS |
$120.42 |
$1,090,046 |
D/D |
(9,047) |
284 |
|
-43% |
|
| Hirmand Mohammad |
EVP and Chief Medical Officer |
• – – |
2021-01-04 |
4 |
OE |
$54.73 |
$478,723 |
D/D |
8,747 |
9,331 |
|
- |
|
| Partridge Andrew John |
EVP & Chief Commercial Officer |
• – – |
2020-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
21,500 |
21,500 |
|
- |
|
| Cui Jingrong Jean |
Director |
– • – |
2020-06-09 |
4 |
AS |
$63.80 |
$625,194 |
I/I |
(9,500) |
540,383 |
|
64% |
|
| Cui Jingrong Jean |
Director |
– • – |
2020-06-08 |
4 |
AS |
$62.50 |
$1,173,888 |
I/I |
(18,500) |
549,883 |
|
74% |
|
| Cui Jingrong Jean |
Director |
– • – |
2020-06-05 |
4 |
AS |
$63.04 |
$1,187,868 |
I/I |
(18,500) |
568,383 |
|
83% |
|
| Cui Jingrong Jean |
Director |
– • – |
2020-06-04 |
4 |
AS |
$61.76 |
$1,198,891 |
I/I |
(18,500) |
586,883 |
|
86% |
|
| George Simeon |
Director |
– • – |
2020-05-21 |
4 |
B |
$60.00 |
$4,999,980 |
I/I |
83,333 |
2,253,660 |
2.1 |
48% |
|
| Countouriotis Athena |
President & CEO |
• • – |
2020-05-21 |
4 |
B |
$60.00 |
$249,960 |
D/D |
4,166 |
26,872 |
2.81 |
48% |
|
| Glaxosmithkline Plc |
Director |
– • – |
2020-05-21 |
4 |
B |
$60.00 |
$4,999,980 |
I/I |
83,333 |
2,253,660 |
2.1 |
48% |
|
| Cui Jingrong Jean |
Director |
– • – |
2020-05-21 |
4 |
AS |
$59.64 |
$417,550 |
I/I |
(7,000) |
605,383 |
|
48% |
|
| Cui Jingrong Jean |
Director |
– • – |
2020-05-20 |
4 |
AS |
$59.04 |
$421,045 |
I/I |
(7,000) |
612,383 |
|
48% |
|
| Cui Jingrong Jean |
Director |
– • – |
2020-05-19 |
4 |
AS |
$56.33 |
$404,108 |
I/I |
(7,000) |
619,383 |
|
52% |
|
| Cui Jingrong Jean |
Director |
– • – |
2020-05-08 |
4 |
AS |
$52.53 |
$619,351 |
I/I |
(11,500) |
626,383 |
|
66% |
|
| Cui Jingrong Jean |
Director |
– • – |
2020-05-07 |
4 |
AS |
$52.22 |
$977,886 |
I/I |
(18,500) |
637,883 |
|
60% |
|
| Cui Jingrong Jean |
Director |
– • – |
2020-05-06 |
4 |
AS |
$52.54 |
$979,323 |
I/I |
(18,500) |
656,383 |
|
58% |
|
142 Records found
|
|
Page 3 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
